SEC 13F Intelligence

Managers / Q2 2024 · view latest →

Tejara Capital Ltd

CIK 0001879713 · 15TH FLOOR, 33 CAVENDISH SQUARE, LONDON, X0, W1G 0PW · 0044(0)2079078566

Reported Value
$275M
Q2 2024
Positions
68
Filings on Record
16
2019–present window
Filed
Aug 14, 2024
original filing

Summary

Tejara Capital Ltd reported $275M in U.S.-listed holdings across 68 positions for Q2 2024.

Its largest position, Roivant Sciences, represents 8.4% of the portfolio.

Compared with Q1 2024, the fund opened 17 new positions and exited 24.

Portfolio Metrics

Turnover
+31.2%
vs prior filed quarter
Top-10 Concentration
+43.8%
share of reported value
Largest Position
+8.4%
Roivant Sciences
New / Exited
17 / 24
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’22: $174MQ4 ’22Q1 ’23: $195MQ2 ’23: $203MQ2 ’23Q3 ’23: $176MQ4 ’23: $239MQ4 ’23Q1 ’24: $272MQ2 ’24: $275MQ2 ’24Q3 ’24: $210MQ4 ’24: $153MQ4 ’24Q1 ’25: $259MQ2 ’25: $216MQ2 ’25Q3 ’25: $192MQ4 ’25: $425MQ4 ’25Q1 ’26: $303Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 60.4%Other: 29.2%ADR: 7.3%ETP: 3.0%
  • Common Stock · 60.4% · $166M
  • Other · 29.2% · $80M
  • ADR · 7.3% · $20M
  • ETP · 3.0% · $8M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2024 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
GPNGLOBAL PMTS INCNEW+95.0K95.0K+$9M$9M
CRCCALIFORNIA RES CORPNEW+131.4K131.4K+$7M$7M
DFSEURDISCOVER FINL SVCSNEW+50.4K50.4K+$7M$7M
MDPEDIATRIX MEDICAL GROUP INCNEW+602.9K602.9K+$5M$5M
COLLCOLLEGIUM PHARMACEUTICAL INCNEW+124.7K124.7K+$4M$4M
ENDEAVOR GROUP HLDGS INCNEW+100.0K100.0K+$3M$3M
SDGRSCHRODINGER INCNEW+101.2K101.2K+$2M$2M
BPBP PLCNEW+48.8K48.8K+$2M$2M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2024

50 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1ROIVANT SCIENCES LTDSHS8.39%$23M2.18M
2AXD2HERON THERAPEUTICS INChistory →COM5.33%$15M4.19M
3ARQTARCUTIS BIOTHERAPEUTICS INChistory →COM4.54%$12M1.34M
4LIBERTY GLOBAL LTDCOM CL A4.06%$11M640.1K
5TRANSOCEAN LTDREGISTERED SHS3.77%$10M1.94M
6NOVNOV INChistory →COM3.73%$10M539.3K
7BORR DRILLING LTDSHS3.61%$10M1.54M
8NABORS INDUSTRIES LTDSHS3.61%$10M139.4K
9MREOMEREO BIOPHARMA GROUP PLChistory →SPON ADS3.42%$9M2.62M
10GPNGLOBAL PMTS INChistory →COM3.34%$9M95.0K
11SLVISHARES SILVER TRhistory →ISHARES2.99%$8M310.0K
12BGCBGC GROUP INChistory →CL A2.70%$7M896.5K
13VTRSVIATRIS INChistory →COM2.70%$7M699.0K
14CRCCALIFORNIA RES CORPhistory →COM STOCK2.54%$7M131.4K
15TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS2.47%$7M418.6K
16DFSEURDISCOVER FINL SVCShistory →COM2.40%$7M50.4K
17NOBLE CORP PLCORD SHS A2.36%$6M145.4K
18NXENEXGEN ENERGY LTDhistory →COM2.18%$6M857.9K
19REKRREKOR SYSTEMS INChistory →COM2.11%$6M3.75M
20OFIXORTHOFIX MED INChistory →COM2.10%$6M434.7K
21GEGGEO GROUP INC NEWhistory →COM1.99%$5M380.9K
22BTUPEABODY ENERGY CORPhistory →COM1.82%$5M225.7K
23MDPEDIATRIX MEDICAL GROUP INChistory →COM1.65%$5M602.9K
24COLLCOLLEGIUM PHARMACEUTICAL INChistory →COM1.46%$4M124.7K
25SLCAUSDU S SILICA HLDGS INChistory →COM1.42%$4M253.0K
26STRATASYS LTDSHS1.39%$4M455.6K
27SLBSCHLUMBERGER LTDhistory →COM STK1.34%$4M78.4K
28FETFORUM ENERGY TECHNOLOGIES INhistory →COM1.34%$4M218.9K
29CRDLCARDIOL THERAPEUTICS INChistory →COM CL A1.26%$3M1.72M
30ADPTADAPTIVE BIOTECHNOLOGIES CORhistory →COM1.20%$3M909.1K
31XPERXPERI INChistory →COMMON STOCK1.12%$3M375.9K
32SCPHSCPHARMACEUTICALS INChistory →COM1.11%$3M704.7K
33ENDEAVOR GROUP HLDGS INCCL A COM0.98%$3M100.0K
34RENEW ENERGY GLOBAL PLCEquity0.98%$3M430.9K
35DMLDENISON MINES CORPCOM0.96%$3M1.32M
36ZYMEZYMEWORKS INCCOM0.84%$2M270.2K
37CONSTELLIUM SEEquity0.72%$2M104.5K
38SDGRSCHRODINGER INCCOM0.71%$2M101.2K
39BIDUNBAIDU INCSPON ADR REP A0.68%$2M21.6K
40CHRSCOHERUS BIOSCIENCES INCCOM0.65%$2M1.03M
41BPBP PLCSPONSORED ADR0.64%$2M48.8K
42HALHALLIBURTON COCOM0.61%$2M50.0K
43QDELQUIDELORTHO CORPCOM0.54%$1M44.4K
44IMVTIMMUNOVANT INCCOM0.53%$1M55.2K
45FIPFTAI INFRASTRUCTURE INCCOMMON STOCK0.53%$1M167.6K
46TSATTELESAT CORPCL A & CL B SHS0.52%$1M158.2K
47MATVMATIV HOLDINGS INCCOM0.52%$1M83.9K
48OSGAMBAC FINL GROUP INCCOM NEW0.47%$1M100.0K
49TRVITREVI THERAPEUTICS INCCOM0.44%$1M406.0K
50XCYOPKO HEALTH INCCOM0.41%$1M905.4K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$303M73May 12, 202613F-HRchanges · EDGAR ↗
Q4 2025$425M62Feb 5, 202613F-HRchanges · EDGAR ↗
Q3 2025$192M47Nov 4, 202513F-HRchanges · EDGAR ↗
Q2 2025$216M70Aug 13, 202513F-HRchanges · EDGAR ↗
Q1 2025$259M75May 13, 202513F-HRchanges · EDGAR ↗
Q4 2024$153M55Feb 10, 202513F-HRchanges · EDGAR ↗
Q3 2024$210M56Nov 13, 202413F-HRchanges · EDGAR ↗
Q2 2024$275M68Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$272M75May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$239M67Feb 12, 202413F-HRchanges · EDGAR ↗
Q3 2023$176M64Nov 15, 2023RESTATEMENTchanges · EDGAR ↗
Q2 2023$203M70Aug 11, 202313F-HRchanges · EDGAR ↗
Q1 2023$195M81May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$174M95Feb 15, 2023RESTATEMENTchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.